SCHEMBL30980985

SCHEMBL30980985

O=c1[nH]c(=O)c2ccc(Cl)nc2[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.49
GRIN3B O60391 1/20 0.49
GRIN1 Q05586 1/20 0.49
GRIN2A Q12879 1/20 0.49
GRIN2B Q13224 1/20 0.49
GRIN2C Q14957 1/20 0.49
GRIN3A Q8TCU5 1/20 0.49
KDM4E B2RXH2 6/20 0.47
CYP1A2 P05177 3/20 0.47
HSD17B10 Q99714 3/20 0.47
BLM P54132 3/20 0.47
LMNA P02545 2/20 0.47
PKM P14618 2/20 0.47
ADORA2A P29274 2/20 0.47
CYP2C19 P33261 2/20 0.47
PMP22 Q01453 2/20 0.47
GMNN O75496 1/20 0.47
TSHR P16473 1/20 0.47
ADORA1 P30542 1/20 0.47
MTOR P42345 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1218582 1.00 GRIN2D (0.49) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL5786187 0.76 SIRT2 (0.60) KDM4ECYP1A2HSD17B10BLMLMNA
SCHEMBL5369123 0.74 KDM4E (0.50) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL30499843 0.73 ALDH1A1 (0.41) KDM4ECYP1A2HSD17B10BLMLMNA
SCHEMBL21949024 0.72 KDM4E (0.50) KDM4ECYP1A2HSD17B10BLMLMNA
SCHEMBL31350659 0.72 FEN1 (0.56) KDM4ECYP1A2HSD17B10BLMLMNA
SCHEMBL30042357 0.70 KDM4E (0.45) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL24342279 0.69 KDM4E (0.44) KDM4ECYP1A2HSD17B10BLMLMNA
SCHEMBL1790858 0.69 KDM4E (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL5368416 0.69 LMNA (0.53) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743462-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS Tay Therapeutics Limited (GB) 2026-05-20 EP disclosed
WO-2025012643-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS Tay Therapeutics Limited (GB) 2025-01-16 WO disclosed
CN-118339146-A Fused pyrimidine derivatives as KRAS oncoprotein inhibitors 贝达医药公司 2024-07-12 CN disclosed